FAST NEWS: Boan Bio pledges shares as collateral for $41 million loan
The Latest: Shandong Boan Biotechnology Co. Ltd. (6955.HK) announced on Friday that it has entered into a loan facility with China Jingu International Trust, whereby Jingu has agreed to lend it…
As its stock gets set for upgrade, Boan Biotech still faces two big risks
Listed at the end of 2022, the biopharmaceutical company is about to have a designation reserved for high-risk stocks removed from its ticker Key Takeaways: With two products now generating…
FAST NEWS: Luye Pharma’s Schizophrenia Drug Wins FDA Approval
The latest: Drug maker Luye Pharma Group Ltd. announced Sunday that its drug Rykindo has been approved by the U.S. Food and Drug Administration (FDA) as a treatment for schizophrenia…
RELATED ARTICLES
-
Fishy loan undercuts Jiumaojiu’s corporate governance image
9922.HK - Health Guard plans dual listing to fund HPV vaccine fight
-
FAST NEWS: Shandong Gold mines higher gold prices for big profits
1787.HK
-
Luzhou Bank’s profit growth looks sweet, but could mask souring loans
1983.HK
-
Lufax takes on more risk, makes Hong Kong acquisition, as its lending shrivels
6623.HK LU.US
- Baiwang eyes Hong Kong IPO to support its money-hungry loan facilitation business
